Validation of tissue microarray technology in breast carcinoma (Q38462822)

3 September 2017

Validation of tissue microarray technology in breast carcinoma (English)

1 reference

3 September 2017

Camp RL

1

1 reference

3 September 2017

Charette LA

series ordinal

2

1 reference

3 September 2017

Rimm DL

series ordinal

3

1 reference

3 September 2017

1 December 2000

1 reference

3 September 2017

Laboratory Investigation

1 reference

3 September 2017

80

1 reference

3 September 2017

1943-1949

1 reference

3 September 2017

12

1 reference

https://scigraph.springernature.com/pub.10.1038/labinvest.3780204

3 September 2017

0 references

cites work

The variability of estrogen receptors in metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780204

Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780204

Met expression is associated with poor outcome in patients with axillary lymph node negative breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780204

Expression of c-met is a strong independent prognostic factor in breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780204

Immunoperoxidase staining for estrogen and progesterone receptors in archival formalin fixed, paraffin embedded breast carcinomas after microwave antigen retrieval

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780204

Tissue microarrays for high-throughput molecular profiling of tumor specimens

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780204

Guardians of the wax ... and the patient.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780204

High-throughput tissue microarray analysis to evaluate genes uncovered by cDNA microarray screening in renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780204

Tissue microarray assessment of prostate cancer tumor proliferation in African- American and white men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780204

Estrogen receptor protein (ERP) in multiple tumor specimens from individual patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780204

Immunohistochemical detection of p53 in archival formalin-fixed tissues of lip and intraoral squamous cell carcinomas from Norway.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780204

7 January 2021

Loss of tumor marker-immunostaining intensity on stored paraffin slides of breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780204

7 January 2021

Tissue heterogeneity of immunohistochemically detected estrogen receptor. Implications for image analysis quantification

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780204

7 January 2021

Neuroendocrine expression in metastatic prostate cancer: evaluation of high throughput tissue microarrays to detect heterogeneous protein expression

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780204

7 January 2021

Brief, high-temperature heat denaturation (pressure cooking): a simple and effective method of antigen retrieval for routinely processed tissues

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780204

7 January 2021

Heterogeneous estrogen receptor levels detected via multiple microsamples from individual breast cancers

1 reference

https://api.crossref.org/works/10.1038%2FLABINVEST.3780204

7 January 2021

10.1038/LABINVEST.3780204

Identifiers

DOI

1 reference

Dimensions Publication ID

3 September 2017

0 references

1 reference